Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Open-label Extension Study Of RN624

ClinicalTrials.gov ID: NCT00399490

Public ClinicalTrials.gov record NCT00399490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 8:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

OPEN-LABEL, MULTIPLE-DOSE STUDY OF THE SAFETY AND EFFICACY OF RN624 IN ADULTS WITH PAIN DUE TO OSTEOARTHRITIS OF THE KNEE.

Study identification

NCT ID
NCT00399490
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Pfizer
Industry
Enrollment
287 participants

Conditions and interventions

Interventions

  • RN624 (PF-04383119) Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 14, 2006
Primary completion
Feb 10, 2008
Completion
Feb 10, 2008
Last update posted
Feb 1, 2021

2006 – 2008

United States locations

U.S. sites
36
U.S. states
23
U.S. cities
27
Facility City State ZIP Site status
BrookWood Internal Medicine Birmingham Alabama 35209
Radiant Research Birmingham Alabama 35209
Arizona Research Center, LLC Phoenix Arizona 85023
Imaging Centers of Anaheim Anaheim California 92801
Orange County Clinical Research Anaheim California 92801
Synergy Clinical Research Center National City California 91950
David M. Radin, MD Stamford Connecticut 06905
Stamford Therapeutics Consortium Stamford Connecticut 06905
Covance Clinical Research Unit, Inc Daytona Beach Florida 32117
Ocala Rheumatology Research Center Ocala Florida 34474-7455
Tampa Medical Group, PA Tampa Florida 33614-7118
Habana Hospital Pharmacy Tampa Florida 33614
Covance Clinical Research Unit, Inc. Honolulu Honolulu Hawaii 96813
Covance Boise Boise Idaho 83704
Northwest Indiana Center for Clinical Research Merrillville Indiana 46410
Office of David Neustadt, PSL Louisville Kentucky 40202
The Center for Rheumatology and Bone Research Wheaton Maryland 20902
Clinical Pharmacology Study Group Worcester Massachusetts 01610
Center for Pharmaceutical Research, P.C. Kansas City Missouri 64114
Quality Clincal Research Omaha Nebraska 68114
Albuquerque Clinical Trials Albuquerque New Mexico 87102
AAIR Research Center Rochester New York 14618
Sports Medicine and Orthopaedics Center Greensboro North Carolina 27401
Pharmquest Greensboro North Carolina 27408
Pharmacotherapy Research Associates Incorporated Zanesville Ohio 43701
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
New Orleans Center for Clinical Research Knoxville Tennessee 37920
Volunteer Research Group Knoxville Tennessee 37920
Office of Walter F. Chase, MD, PA Austin Texas 78705
Radiant Research - San Antonio San Antonio Texas 78217
Radiant Research San Antonio Northeast San Antonio Texas 78217
Rheumatology Associates of South Texas San Antonio Texas 78217
South Texas Radiology Imaging Center San Antonio Texas 78217
Pivotal Research Midvale Utah 84047
Charlottesville Medical Research Charlottesville Virginia 22911
Clinical Trials Northwest Yakima Washington 98902

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00399490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 1, 2021 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00399490 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →